Literature DB >> 33412082

Population-based study of a free rubella-specific antibody testing and immunization campaign in Chiba city in response to the 2018-2019 nationwide rubella outbreak in Japan.

Kenichi Takeshita1, Noriko Takeuchi1, Misako Ohkusu1, Mihoko Ohata1, Mamiko Suehiro2, Hisashi Maejima2, Hiroki Abe3, Fumio Ohta3, Yoichi Ohama3, Kazuto Tamai3, Mana Haraki3, Naruhiko Ishiwada1.   

Abstract

Japan has not been able to eliminate rubella; as a result, the large rubella epidemic has occurred. Considering the complicated history of the vaccine policy in Japan, some susceptible populations became infected with rubella, resulting in an outbreak. We conducted a large serosurveillance against rubella in Chiba city after initiating free rubella-specific antibody testing and an immunization campaign during 2018-2019. The total number of rubella specific antibody tests that was conducted in the nationwide campaign and Chiba city original campaign was 8277 and 6104, respectively. The proportion of participants with an antibody titer of ≤1:16 using the hemagglutination inhibition (HI) test was higher in those in their 20-30s. On the contrary, the proportion of participants with an antibody titer of <1:8 using the HI test was higher in men in their 40-50s. This discrepancy possibly reflects the complicated history of the vaccine policy. The number of participants in the nationwide immunization campaign in this city was 1517, whereas that in the Chiba city campaign was 3607. The Chiba city campaign was effective against women in their 20-30s (child-bearing generation); however, the nationwide campaign was not sufficiently effective against men in their 40-50s because many workers were did not visit medical facilities to receive the measles-rubella vaccine.

Entities:  

Keywords:  Japan; Rubella; immunization campaign; measles–rubella vaccine; rubella specific antibody testing; serosurveillance

Mesh:

Substances:

Year:  2021        PMID: 33412082      PMCID: PMC8115751          DOI: 10.1080/21645515.2020.1847584

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  12 in total

1.  A case of adult rubella in Japan.

Authors:  Sayaka Tago; Yuji Hirai
Journal:  Int J Infect Dis       Date:  2019-02-27       Impact factor: 3.623

2.  Towards rubella elimination in Japan.

Authors:  Kazuaki Jindai; Takanori Funaki; Takeshi Nishijima; Shunji Takakura; Hiroyuki Noda; Kuniaki Miyake
Journal:  Lancet Infect Dis       Date:  2018-07       Impact factor: 25.071

3.  Serological assessment of measles-rubella vaccination catch-up campaign among university students.

Authors:  Jiro Takeuchi; Masashi Goto; Takashi Kawamura; Atsushi Hiraide
Journal:  Pediatr Int       Date:  2014-04-28       Impact factor: 1.524

4.  Epidemiological characteristics of rubella and congenital rubella syndrome in the 2012-2013 epidemics in Tokyo, Japan.

Authors:  Yoshiyuki Sugishita; Naotaka Shimatani; Shigetaka Katow; Takuri Takahashi; Narumi Hori
Journal:  Jpn J Infect Dis       Date:  2014-12-24       Impact factor: 1.362

5.  Vaccination Status and Antibody Titers against Rubella and Measles among Japanese Female College Students Majoring in Childcare between 2015 and 2018.

Authors:  Yoshifumi Shoho; Takao Kimura; Yoshimaro Yanagawa; Ai Saito; Toshiya Inoue; Chiaki Suto; Katsuhiko Tsunekawa; Osamu Araki; Makoto Nara; Yutaka Tokue; Masami Murakami
Journal:  Tohoku J Exp Med       Date:  2018-10       Impact factor: 1.848

6.  Changes in the prevalence of the measles, rubella, varicella-zoster, and mumps virus antibody titers in Japanese pregnant women.

Authors:  Masachi Hanaoka; Michi Hisano; Noriyoshi Watanabe; Kana Sugawara; Yukari Kambe; Eriko Kanda; Haruhiko Sago; Tatsuo Kato; Koushi Yamaguchi
Journal:  Vaccine       Date:  2013-03-21       Impact factor: 3.641

7.  Evaluation of measles-rubella vaccination for mothers in early puerperal phase.

Authors:  Michi Hisano; Tatsuo Kato; Eisuke Inoue; Haruhiko Sago; Koushi Yamaguchi
Journal:  Vaccine       Date:  2016-01-19       Impact factor: 3.641

8.  Epidemiological changes in rubella IgG antibody levels detected in antenatal women from a retrospective rubella seroprevalence study.

Authors:  Ciara O'Connor; David Le Blanc; Richard J Drew
Journal:  Ir J Med Sci       Date:  2017-12-05       Impact factor: 2.089

9.  Impact of vaccination on measles, mumps, and rubella antibody titers in Japanese healthcare workers: An observational study.

Authors:  Taku Ogawa; Takashi Inoue; Kei Kasahara; Mitsuru Konishi; Keiichi Mikasa
Journal:  PLoS One       Date:  2020-03-24       Impact factor: 3.240

10.  Conjunctivitis, the key clinical characteristic of adult rubella in Japan during two large outbreaks, 2012-2013 and 2018-2019.

Authors:  Hidetoshi Nomoto; Masahiro Ishikane; Takato Nakamoto; Masayuki Ohta; Shinichiro Morioka; Kei Yamamoto; Satoshi Kutsuna; Shunsuke Tezuka; Junwa Kunimatsu; Norio Ohmagari
Journal:  PLoS One       Date:  2020-04-24       Impact factor: 3.752

View more
  1 in total

1.  Epidemiological characteristic of rubella by age group during 12 years after the national introduction of rubella vaccine in Hangzhou, China.

Authors:  Jun Wang; Yuyang Xu; Xiaozhen Wang; Yan Liu; Xiaoping Zhang; Jian Du; Xinren Che; Wenwen Gu; Xuechao Zhang; Wei Jiang; Yi Wang
Journal:  Hum Vaccin Immunother       Date:  2022-03-28       Impact factor: 4.526

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.